
Shiv Pharma
SuratMOUNJARO is a glucose-dependent insulinotropic polypeptide
(GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
indicated as an adjunct to diet and exercise to improve glycemic
control in adults with type 2 diabetes mellitus. (1)
Limitations of Use:
• Has not been studied in patients with a history of pancreatitis (1,5.2)
• Is not indicated for use in patients with type 1 diabetes mellitus (1)
View export-ready suppliers